Craft
  • Home
  •  / Tessa Therapeutics
Tessa Therapeutics

Tessa Therapeutics

Total Funding

$80 M

Tessa Therapeutics Summary

Company summary

Overview
Tessa Therapeutics is a biotechnology company specializing in the research, clinical development, and commercialization of cancer immunotherapy treatments. The Company is engaged in employing Virus-Specific T cells to treat cancer, and conducting US FDA-registered Phase III T cell therapy trial in NPC, or any cancer indication.
Type
Private
Founded
2011
HQ
Singapore, SG | view all locations
Website
https://www.tessacell.com
Cybersecurity rating
Sectors

Key people

  • Teo Ming Kian

    Teo Ming Kian, Chairman

    • Göran Ando

      Göran Ando, Chairman

      • Jeffrey H. Buchalter

        Jeffrey H. Buchalter, Director & CEO

        • John Ng

          John Ng, Chief Operations Officer

          LocationsView all

          1 location detected

          • Singapore HQ

            Singapore

            8 Temasek Boulevard, #24-02 Suntec Tower 3

          Footer menu